What is Ardelyx's SG&A?

Ardelyx (ARDX) reported SG&A of $102.27M in Q1 2026.

How has Ardelyx's SG&A changed year-over-year?

Ardelyx's SG&A increased by 22.9% year-over-year, from $83.22M to $102.27M.

What is the long-term trend for Ardelyx's SG&A?

Over 4 years (2021 to 2025), Ardelyx's SG&A has grown at a 47.0% compound annual growth rate (CAGR), from $72.3M to $337.23M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Ardelyx ARDX SG&A

SG&A at other companies

AmgenAMGN

$1.6B-5.0%

Bausch Health CompaniesBHC

$861M-0.7%

AbbVieABBV

$3.58B+8.7%

XER

Xeris Biopharma Holdings, Inc.XERS

$53.14M+20.7%

Neurocrine BiosciencesNBIX

$318.5M+15.2%

Agios PharmaceuticalsAGIO

$48.3M+16.3%

Other financials

Income statement

See full

Revenue$94.5M+27.5%

Gross profit$89.7M+45.1%

Operating income-$32.8M+9.8%

Net income-$37.6M+8.6%

EPS (diluted)-$0.15+11.8%

Balance sheet

See full

Cash & equivalents$31.2M+1.3%

Total debt$208.3M+34.3%

Total equity$148.6M+2.0%

Total assets$504.5M+23.0%

Cash flow

See full

Operating cash flow-$32.2M+16.2%

CapEx$69.0K-78.8%

Free cash flow-$32.3M+16.7%

Valuation

See full

Market cap$1.53B+79.5%

Enterprise value$1.71B+74.8%

P/S3.6×+1.2×

Profitability

See full

Gross margin92.5%+7.9pp

Operating margin-25.4%—

Net margin-13.6%—

FCF margin-40.9%—

Returns & leverage

See full

Return on equity-39.5%—

Debt / equity1.4×+0.3×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardelyx's SG&A?: Ardelyx (ARDX) reported SG&A of $102.27M in Q1 2026.
How has Ardelyx's SG&A changed year-over-year?: Ardelyx's SG&A increased by 22.9% year-over-year, from $83.22M to $102.27M.
What is the long-term trend for Ardelyx's SG&A?: Over 4 years (2021 to 2025), Ardelyx's SG&A has grown at a 47.0% compound annual growth rate (CAGR), from $72.3M to $337.23M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.